CAS RN: 103213-60-1

CIS-13-DOCOSENOIC ANHYDRIDE

Product Availability

Choose a grade to view its available package options.

3 package records3 with current stock1 grade group
Batch No.PackageAvailabilityInquiry
Batchno.20260508 100mg In stock Inquiry
Batchno.20250526 1g In stock Inquiry
Batchno.20250102 250mg In stock Inquiry
  • Product code: starshine_CAS103213-60-1
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

103213-60-1 / [(Z)-docos-13-enoyl] (Z)-docos-13-enoate

Docos-13-enoyl Docos-13-enoate | docos-13-enoic anhydride | SCHEMBL3290720

Standard CAS: 103213-60-1 Multi CAS: Yes

Basic Information

CAS
103213-60-1
Multi CAS
Yes
Molecular Formula
C44H82O3
Molecular Weight
659.100000
Exact Mass
658.626396
SMILES
CCCCCCCC/C=C\CCCCCCCCCCCC(=O)OC(=O)CCCCCCCCCCC/C=C\CCCCCCCC
InChI
InChI=1S/C44H82O3/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-35-37-39-41-43(45)47-44(46)42-40-38-36-34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h17-20H,3-16,21-42H2,1-2H3/b19-17-,20-18-
InChIKey
LVWSCSGKAPKSBZ-CLFAGFIQSA-N
Synonyms
Docos-13-enoyl Docos-13-enoate docos-13-enoic anhydride SCHEMBL3290720 DTXSID90394622 DB-040429

Computed Properties

Structural Parameters

Heavy atom count
47
Fraction Csp3
0.86
Rotatable bonds
38
H-bond acceptors
3
Molar refractivity
206.94
TPSA
43.37

LogP / Solubility

WLOGP
15.25
MLOGP
13.48
XLogP3
19.2
Consensus LogP
15.98
Log S (ESOL)
-11.03
Class (ESOL)
Insoluble
Log S (Ali)
-15.98
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-21.16
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
No
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
4.09

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
4

Safety & Transport

GHS Hazard Statements
Not Classified Reported as not meeting GHS hazard criteria by 2 of 2 companies. For more detailed information, please visit ECHA C&L website.

Get In Touch

Contact Us